Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug
SEC filing record 1 source field available
Fiscal year end
31 December
CRISPR Therapeutics AG has filed 853 SEC EDGAR filings since 13 May 2016

SEC filing history

Showing 751-775 of 853 matching filings.

Per page
25
Current page
31
4

FORM 4 SUBMISSION

Filing date
01 Jun 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
01 Jun 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2017
Reporting date
16 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
11 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2017
Reporting date
05 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 May 2017
Reporting date
03 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 May 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
04 May 2017
Reporting date
03 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Apr 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Apr 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
27 Apr 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37923

DEFA14A

Filing date
18 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37923

DEF 14A

Filing date
18 Apr 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
13 Apr 2017
Reporting date
13 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37923

PRE 14A

Filing date
04 Apr 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
31 Mar 2017
Reporting date
28 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
20 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .